Table 2.
Scene | Events | Ref. |
---|---|---|
1. Around producer cells |
a. CAFs and cancer cells are major producers of matrix proteins. | [51,52] |
b. EVs are embedded within ECM and accumulated around producer cells. | [70] | |
c. EVs and ECM mutually promote their accumulation around cells. | [70] | |
d. sEVs act similar to car wheels to help cells migrate on rails of fibronectin. | [71] | |
e. MMPs cleave matrix proteins to release matrix vesicles, growth factors, and chemokines. | [72] | |
f. MMPs destroy ECM to increase the accessibility of proteins, EVs, and drugs to target cells. | [70] | |
2. In bodily fluids (or tissue culture supernatant) |
a. EVs are often coated with matrix (fibronectin, proteoglycan, agrin, tenascin, hyaluronan). | [64,73] |
b. EV surface MMPs promote the dissemination of EVs. | [7] | |
3. At niches (at local and distant tissues) |
a. EV surface integrins bind to ECM, leading to niche formation. | [74] |
b. EV surface matrices bind to ECM on the surface of recipient cells. | [75] | |
c. EV surface growth factors, cytokines and chemokines determine uptake and bio distribution. | [76] | |
d. MMPs loaded in EVs are transferred into recipient cell nuclei and transactivate the CCN2 gene, encoding a matricellular protein. | [7] | |
e. EV surface MMPs promote the penetration of EVs into target tissues. | [8] |